183 related articles for article (PubMed ID: 35504741)
1. Meta-Analysis of Catheter Ablation Outcomes in Patients With Cardiac Sarcoidosis Refractory Ventricular Tachycardia.
Adhaduk M; Paudel B; Liu K; Ashwath M; Giudici M
Am J Cardiol; 2022 Jul; 174():136-142. PubMed ID: 35504741
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
[TBL] [Abstract][Full Text] [Related]
3. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
Jefic D; Joel B; Good E; Morady F; Rosman H; Knight B; Bogun F
Heart Rhythm; 2009 Feb; 6(2):189-95. PubMed ID: 19187909
[TBL] [Abstract][Full Text] [Related]
4. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.
Papageorgiou N; Providência R; Bronis K; Dechering DG; Srinivasan N; Eckardt L; Lambiase PD
Europace; 2018 Apr; 20(4):682-691. PubMed ID: 28444174
[TBL] [Abstract][Full Text] [Related]
5. Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis.
Kaur D; Roukoz H; Shah M; Yalagudri S; Pandurangi U; Chennapragada S; Narasimhan C
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):612-620. PubMed ID: 31916658
[TBL] [Abstract][Full Text] [Related]
6. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis.
Naruse Y; Sekiguchi Y; Nogami A; Okada H; Yamauchi Y; Machino T; Kuroki K; Ito Y; Yamasaki H; Igarashi M; Tada H; Nitta J; Xu D; Sato A; Aonuma K
Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):407-13. PubMed ID: 24837644
[TBL] [Abstract][Full Text] [Related]
7. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
[TBL] [Abstract][Full Text] [Related]
8. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
[TBL] [Abstract][Full Text] [Related]
9. Catheter Ablation of Ventricular Tachycardia in Patients With a Ventricular Assist Device: A Systematic Review of Procedural Characteristics and Outcomes.
Anderson RD; Lee G; Virk S; Bennett RG; Hayward CS; Muthiah K; Kalman J; Kumar S
JACC Clin Electrophysiol; 2019 Jan; 5(1):39-51. PubMed ID: 30678785
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.
Turagam MK; Vuddanda V; Atkins D; Santangeli P; Frankel DS; Tung R; Vaseghi M; Sauer WH; Tzou W; Mathuria N; Nakahara S; Dickfeld TM; Bunch TJ; Weiss P; Di Biase L; Tholakanahalli V; Vakil K; Tedrow UB; Stevenson WG; Della Bella P; Shivkumar K; Marchlinski FE; Callans DJ; Natale A; Reddy M; Lakkireddy D
JACC Clin Electrophysiol; 2017 Dec; 3(13):1534-1543. PubMed ID: 29759835
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Garg J; Kewcharoen J; Shah K; Turagam M; Bhardwaj R; Contractor T; Mandapati R; Lakkireddy D
J Cardiovasc Electrophysiol; 2023 Jan; 34(1):219-224. PubMed ID: 36335616
[TBL] [Abstract][Full Text] [Related]
12. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Muser D; Santangeli P; Pathak RK; Castro SA; Liang JJ; Magnani S; Hayashi T; Garcia FC; Hutchinson MD; Supple GE; Frankel DS; Riley MP; Lin D; Schaller RD; Desjardins B; Dixit S; Callans DJ; Zado ES; Marchlinski FE
Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516457
[TBL] [Abstract][Full Text] [Related]
14. Drug-refractory ventricular tachycardias after myocarditis: endocardial and epicardial radiofrequency catheter ablation.
Dello Russo A; Casella M; Pieroni M; Pelargonio G; Bartoletti S; Santangeli P; Zucchetti M; Innocenti E; Di Biase L; Carbucicchio C; Bellocci F; Fiorentini C; Natale A; Tondo C
Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):492-8. PubMed ID: 22294614
[TBL] [Abstract][Full Text] [Related]
15. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
[TBL] [Abstract][Full Text] [Related]
16. Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis.
Okada DR; Assis FR; Gilotra NA; Ha JS; Berger RD; Calkins H; Chrispin J; Mandal K; Tandri H
Heart Rhythm; 2019 Sep; 16(9):1408-1413. PubMed ID: 30818090
[TBL] [Abstract][Full Text] [Related]
17. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device.
Aryana A; Gearoid O'Neill P; Gregory D; Scotti D; Bailey S; Brunton S; Chang M; d'Avila A
Heart Rhythm; 2014 Jul; 11(7):1122-30. PubMed ID: 24732372
[TBL] [Abstract][Full Text] [Related]
18. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
[TBL] [Abstract][Full Text] [Related]
19. Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation.
Arya A; Eitel C; Bollmann A; Wetzel U; Sommer P; Gaspar T; Husser D; Piorkowski C; Hindricks G
Pacing Clin Electrophysiol; 2010 Nov; 33(11):1312-8. PubMed ID: 20723092
[TBL] [Abstract][Full Text] [Related]
20. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
